Purchase Order 36C25722P0705
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8), awarded a delivery order valued at $96,960 to Veracyte, Inc. for gene testing services. The award, issued on February 5, 2026, is a firm fixed-price delivery order with an ultimate completion date of February 4, 2027, and carries no small business set-aside designation. The contract will be performed in South San Francisco, California, where Veracyte maintains its headquarters. This delivery order is issued under...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23), awarded a delivery order to Veracyte, Inc. for reference laboratory services under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The award, issued on May 1, 2024, carries a ceiling value of $11.2K and an ultimate completion date of April 30, 2025. Veracyte, Inc., a South San Francisco-based medical diagnostic company specializing in advanced genomic testing, will deliver molecular and genomic...
- Veracyte, Inc. was awarded a $96,960 delivery order for gene testing services from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The firm fixed price order is associated with the Medical Laboratory Testing and Analysis Services Government-Wide Acquisition Contract and has a completion date of February 4, 2025. Veracyte will provide the genomic classifier laboratory testing at its facility located in South San Francisco, California to...
- This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Veracyte, Inc., a for-profit corporation based in South San Francisco, California. The contract is for Veracyte's reference laboratory services to the VA's Veterans Integrated Service Network (VISN) 23. The contract has a total ceiling value of $45,200.00 and is a firm fixed-price delivery order with an ultimate completion date of April 30, 2026. The contract is not set aside for any specific business...
- This firm fixed-price purchase order for $77,700 was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services. The contract is for Afirma Gene Expression Classifier and Atlas Expression Classifier testing, which analyze gene expression patterns in thyroid biopsy samples to determine malignancy risk and aid in diagnosis and treatment decisions for veterans. This award is not set...
- This federal contract award is for a task order under the NWI VAHCS TASK ORDER VERACYTE REFERENCE LABORATORY SERVICES IDIQ, a $62,000.00 firm fixed-price delivery order contract awarded to Veracyte, Inc., a for-profit medical diagnostic company headquartered in South San Francisco, California. The contract is with the Veterans Integrated Service Network 23 (VISN 23), a civilian agency under the Department of Veterans Affairs, for reference laboratory services. Veracyte will provide specialized...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (VISN 23), awarded a delivery order valued at $168,000 to Veracyte, Inc. for reference laboratory services with a completion date of April 30, 2026. This task order was issued under an existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Veracyte Reference Laboratory Services with VISN 23, which carries a total ceiling value of $2 million through April 2028. The contract utilizes firm fixed pricing and was...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostic company, by the Veterans Integrated Service Network 23 (VISN 23), a division of the Department of Veterans Affairs (VA). The contract is an Indefinite Delivery, Indefinite Quantity (IDIQ) with a ceiling value of $112,200.00 for reference laboratory services. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2026. The contract is not set aside and was awarded on May 1,...
- This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostics company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16). The contract is for $405,018.00 and involves the provision of genomic testing services, specifically Veracyte's proprietary genomic testing products and services. This is a firm fixed-price purchase order contract with a period of performance ending on May 31, 2029. The contract is not set aside and appears to...
- This firm fixed-price purchase order was awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs to Veracyte, Inc., a for-profit provider of genomic testing services, to conduct referral laboratory testing for thyroid genomic expression classifier (GEC) testing. The $202,552.00 contract has a period of performance through September 30, 2024. Veracyte has provided similar genomic testing services to support cancer detection and diagnosis for...
Veracyte, Inc. was awarded a $451.2K firm fixed-price purchase order by Veterans Integrated Service Network 17 (VISN 17), a civilian component of the Department of Veterans Affairs, for genomic laboratory testing services. The contract was awarded on August 15, 2022, with an ultimate completion date of August 14, 2027, and will be performed in Dallas, Texas. This award carries no small business set-aside designation and represents a continuation of Veracyte's established relationship with the VA's precision medicine and personalized cancer care initiatives. Veracyte, Inc., headquartered in South San Francisco, California, is a specialized medical diagnostic company providing advanced genomic testing services focused on cancer risk assessment and treatment planning. The company's federal portfolio includes proprietary tests such as the Decipher Prostate Cancer genomic classifier and Afirma thyroid nodule assessment tools, delivered across multiple Veterans Integrated Service Networks, the Defense Health Agency, and Indian Health Service through various indefinite delivery vehicles and blanket purchase agreements under the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule. This VISN 17 purchase order aligns with Veracyte's broader federal contracting activity, which demonstrates extensive experience delivering specialized molecular diagnostic services to support VA healthcare delivery and precision medicine applications across multiple veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00010 | Supplemental Agreement for work within scope | ($61k) | 2/5/26 | |
| P00009 | Exercise an Option | $128.0k | 6/27/25 | |
| P00007 | Supplemental Agreement for work within scope | ($51k) | 1/10/25 | |
| P00006 | Supplemental Agreement for work within scope | ($3k) | 9/26/24 | |
| P00004 | Exercise an Option | $131.0k | 7/12/24 |